[HTML][HTML] CADTH Health Technology Review Ibrutinib for Chronic Graft-Versus-Host Disease
SD Khangura, A Grobelna - canjhealthtechnol.ca
Currently available evidence describing second-or third-line therapies for treatment-
refractory chronic graft-versus-host disease was ineligible for this review because of the use …
refractory chronic graft-versus-host disease was ineligible for this review because of the use …
[HTML][HTML] CADTH Health Technology Review Ibrutinib for Chronic Graft-Versus-Host Disease
SD Khangura, A Grobelna - canjhealthtechnol.ca
Currently available evidence describing second-or third-line therapies for treatment-
refractory chronic graft-versus-host disease was ineligible for this review because of the use …
refractory chronic graft-versus-host disease was ineligible for this review because of the use …